[1] R. Ross, "Athresclerosis - an inflammatory disease," N. Engl. J. Med. 340(2), 115–126 (1999).
[2] A. J. Lusis, "Atherosclerosis," Nature 407(6801), 233–241 (2000).
[3] P. Libby, "Inflammation in atherosclerosis," Nature 420(6917), 868–874 (2002).
[4] G. K. Hansson, P. Libby, "The immune response in atherosclerosis: A double-edged sword," Nat. Rev. Immunol. 6(7), 508–519 (2006).
[5] C. Weber, A. Zernecke, P. Libby, "The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models," Nat. Rev. Immunol. 8(10), 802–815 (2008).
[6] P. Libby, G.-P. Shi, "Mast cells as mediators and modulators of atherogenesis," Circulation 115(19), 2471–2473 (2007).
[7] P. T. Kovanen, "Mast cells: Multipotent local effector cells in atherothrombosis," Immun. Rev. 217(1), 105–122 (2007).
[8] I. Bot, G.-P. Shi, P. T. Kovanen, "Mast cells as effectors in atherosclerosis," Arterioscler. Thromb. Vascu. Biol. 35(2), 265–271 (2015).
[9] G.-P. Shi, I. Bot, P. T. Kovanen, "Mast cells in human and experimental cardiometabolic diseases," Nat. Rev. Cardiol. 12(11), 643–658 (2015).
[10] L. S. Ramalho et al., "Role of mast cell chymase and tryptase in the progression of atherosclerosis: Study in 44 autopsied cases," Ann. Diagn. Pathol. 17(1), 28–31 (2013).
[11] J. Sun et al., "Mast cells promote atherosclerosis by releasing proinflammatory cytokines," Nat. Med. 13(6), 719–724 (2007).
[12] P. T. Kovanen, "Mast cells and degradation of pericellular and extracellular matrices: Potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques," Biochem. Soc. Trans. 035(5), 857–861 (2007).
[13] J. L. Johnson et al., "Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques," Arterioscler. Thromb. Vasc. Biol. 18(11), 1707–1715 (1998).
[14] M. J. Leskinen, P. T. Kovanen, K. A. Lindstedt, "Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells — a potential mechanism for the weakening and rupture of atherosclerotic plaques," Biochem. Pharmacol. 66(8), 1493–1498 (2003).
[15] F. A. Jaffer, P. Libby, R. Weissleder, "Molecular imaging of cardiovascular disease," Circulation 116 (9), 1052–1061 (2007).
[16] J. Oh et al., "Detection of macrophages in atherosclerotic tissue using magnetic nanoparticles and differential phase optical coherence tomography," J. Biomed. Opt. 13(5), 054006–054008 (2008).
[17] R. N. Germain et al., "Dynamic imaging of the immune system: Progress, pitfalls and promise," Nat. Rev. Immunol. 6(7), 497–507 (2006).
[18] W. Yu et al., "In vivo imaging of atherosclerotic plaques in apolipoprotein E deficient mice using nonlinear microscopy," J. Biomed. Opt. 12(5), 054008–054010 (2007).
[19] R. T. A. Megens et al., "Two-photon microscopy on vital carotid arteries: Imaging the relationship between collagen and inflammatory cells in atherosclerotic plaques," J. Biomed. Opt. 13(4), 044022-10 (2008).
[20] C. Li, R. K. Pastila, C. P. Lin, "Imaging immune response of skin mast cells in vivo with two-photon microscopy," SPIE Photonics West, San Francisco, CA (2012).
[21] A. Zoumi, A. Yeh, B. J. Tromberg, "Imaging cells and extracellular matrix in vivo by using second-harmonic generation and two-photon excited fluorescnece," Proc. Natl. Acad. Sci. USA 99(17), 11014 (2007).
[22] P. J. Campagnola, L. M. Loew, "Second-harmonic imaging microscopy for visualizing biomolecular arrays in cells, tissues and organisms," Nat. Biotech. 21(11), 1356–1360 (2003).
[23] I. Veilleux et al., "In vivo cell tracking with video rate multimodality laser scanning microscopy," IEEE J. Sel. Top. Quant. Electron. 14(1), 10–18 (2008).
[24] C. Li et al., "Imaging leukocyte trafficking in vivo with two-photon-excited endogenous tryptophan fluorescence," Opt. Express 18(2), 988–999 (2010).
[25] L. J. Walsh, "Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-[alpha]," Immunol. Cell. Biol. 73(3), 226–233 (1995).
[26] S. Huang, A. A. Heikal, W. W. Webb, "Two-photon fluorescence spectroscopy and microscopy of NAD(P)H and flavoprotein," Biophys. J. 82(5), 2811–2825 (2002).
[27] L. Liu et al., "Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography," Nat. Med. 17(8), 1010– 1014 (2011).